.png)
.png)
Clinical Director and Associate Chief, Division of Infectious Diseases
Program Director, Pediatric Infectious Diseases Fellowship Program
Boston Children's Hospital
Boston, MA, United States
Tanvi Sharma, MD, MPH is co-director of the immunocompromised hosts infectious diseases (ID) service and co-director of ID in the Pediatric Transplant Center at Boston Children’s Hospital. She is an assistant professor of pediatrics at Harvard Medical School. Dr. Sharma serves as the associate chief and clinical director within the division of pediatric ID, and also serves as director of the pediatric ID fellowship program at Boston Children’s Hospital. Dr. Sharma completed her medical training, residency in pediatrics, and fellowship in pediatric ID at University of Miami/Jackson Memorial Medical Center in Miami, Florida. She joined the faculty with the divisions of pediatric ID/immunology and pediatric clinical research at the University of Miami before moving to Boston. Her early research interests focused on metabolic complications in children with perinatally-acquired HIV infection receiving antiretroviral therapy, and have since evolved to evaluating infectious outcomes in children undergoing solid organ and hematopoietic stem cell transplantation. As both an educator and clinician caring for children with immunocompromising conditions, Dr. Sharma has additionally take on an active role in the development of curricula and training experiences focused on pediatric immunocompromised hosts infectious diseases. Dr. Sharma serves in a number of leadership roles within the Pediatric Infectious Diseases Society (PIDS), including as a member of the PIDS Board of Directors, and also within the Infectious Diseases Society of America (IDSA), and the American Society of Transplantation (AST).
I do not have any relevant financial / non-financial relationships with any proprietary interests.
Wednesday, October 19, 2022
8:00 AM – 12:15 PM US ET
Wednesday, October 19, 2022
8:10 AM – 9:50 AM US ET
Friday, October 21, 2022
10:30 AM – 11:45 AM US ET